NCT06115408View on ClinicalTrials.gov

Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Uterine Leiomyoma
Interventions
DRUG

Dienogest 2 MG

Clinical trial

DRUG

N-acetyl cysteine

Clinical trial

Trial Locations (1)

Unknown

Ainshams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06115408 - Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma | Biotech Hunter | Biotech Hunter